This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tenet Reports Third Quarter Adjusted EBITDA Growth Of 40% To $269 Million

Tenet Healthcare Corporation (NYSE:THC) today reported Adjusted EBITDA of $269 million for the third quarter ended September 30, 2012, an increase of $77 million, or 40 percent, as compared to Adjusted EBITDA of $192 million in the third quarter of 2011. Net income attributable to common shareholders was $40 million, or $0.37 per diluted share, compared to $6 million, or $0.05 per diluted share in the third quarter of 2011.

“Strong revenue growth and disciplined cost control continue to drive our solid financial performance,” said Trevor Fetter, president and chief executive officer. “Adjusted EBITDA increased 40 percent to create the Company’s strongest third quarter in the last ten years. Net revenues grew by 5.8 percent reflecting strong volume increases and continued pricing strength. Our volume growth was one of the strongest in the investor-owned healthcare provider sector, and we recorded our eighth consecutive quarter of positive growth in adjusted admissions. Volume growth was led by a 6.3 percent increase in outpatient surgeries. Cost control was excellent. Conifer Health Solutions, Tenet’s services business, reported another solid quarter contributing $24 million to Adjusted EBITDA.”

“As we look to the fourth quarter, state officials in California recently informed the hospital industry that the managed care portion of the California Provider Fee program is not likely to be approved in 2012,” said Mr. Fetter. “This program had been expected to contribute more than $40 million to Adjusted EBITDA in the fourth quarter. We now expect these earnings to be recognized in 2013. As a result of this delay and recent trends in volumes and payer mix, we now expect Adjusted EBITDA of approximately $1.2 billion for 2012.”

Discussion of Results (Percentage changes compare Q3’12 to Q3’11, unless otherwise noted.)

In the third quarter, adjusted admissions increased by 1.4 percent, and total admissions declined by 0.5 percent. Outpatient surgeries extended their strong growth trend increasing by 6.3 percent and total emergency department visits increased by 4.9 percent.

1 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,776.43 +304.06 1.85%
S&P 500 1,988.15 +36.79 1.89%
NASDAQ 4,785.3040 +77.5290 1.65%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs